![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SRBD1 |
Gene summary for SRBD1 |
![]() |
Gene information | Species | Human | Gene symbol | SRBD1 | Gene ID | 55133 |
Gene name | S1 RNA binding domain 1 | |
Gene Alias | SRBD1 | |
Cytomap | 2p21 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q8N5C6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55133 | SRBD1 | NAFLD1 | Human | Liver | NAFLD | 1.65e-09 | 7.58e-01 | -0.04 |
55133 | SRBD1 | HCC1_Meng | Human | Liver | HCC | 2.95e-22 | -4.07e-02 | 0.0246 |
55133 | SRBD1 | HCC2_Meng | Human | Liver | HCC | 4.37e-04 | -3.03e-02 | 0.0107 |
55133 | SRBD1 | HCC1 | Human | Liver | HCC | 3.76e-02 | 4.29e+00 | 0.5336 |
55133 | SRBD1 | HTA12-25-1 | Human | Pancreas | PDAC | 1.85e-05 | 6.44e-01 | 0.313 |
55133 | SRBD1 | HTA12-26-1 | Human | Pancreas | PDAC | 1.24e-12 | 6.97e-01 | 0.3728 |
55133 | SRBD1 | HTA12-29-1 | Human | Pancreas | PDAC | 2.09e-22 | 5.78e-01 | 0.3722 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SRBD1 | SNV | Missense_Mutation | c.1148N>T | p.Thr383Met | p.T383M | Q8N5C6 | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-98-8020-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
SRBD1 | SNV | Missense_Mutation | novel | c.935C>T | p.Ser312Phe | p.S312F | Q8N5C6 | protein_coding | tolerated(0.43) | benign(0.038) | TCGA-BB-A6UO-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
SRBD1 | SNV | Missense_Mutation | rs762131349 | c.1363N>A | p.Ser455Thr | p.S455T | Q8N5C6 | protein_coding | deleterious(0.02) | benign(0.031) | TCGA-CN-4730-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SRBD1 | SNV | Missense_Mutation | novel | c.89N>T | p.Ala30Val | p.A30V | Q8N5C6 | protein_coding | tolerated_low_confidence(0.1) | benign(0.051) | TCGA-CV-7568-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SRBD1 | insertion | Frame_Shift_Ins | novel | c.137_138insG | p.Val47SerfsTer6 | p.V47Sfs*6 | Q8N5C6 | protein_coding | TCGA-H7-8502-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | unknown | SD | ||
SRBD1 | insertion | In_Frame_Ins | novel | c.136_137insCACTAC | p.Lys46delinsThrLeuGln | p.K46delinsTLQ | Q8N5C6 | protein_coding | TCGA-H7-8502-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | unknown | SD | ||
SRBD1 | SNV | Missense_Mutation | rs760462309 | c.1456T>C | p.Tyr486His | p.Y486H | Q8N5C6 | protein_coding | tolerated(0.81) | benign(0) | TCGA-KK-A7B0-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Hormone Therapy | leuprolide | SD |
SRBD1 | SNV | Missense_Mutation | c.1646G>C | p.Gly549Ala | p.G549A | Q8N5C6 | protein_coding | deleterious(0.01) | possibly_damaging(0.862) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
SRBD1 | SNV | Missense_Mutation | rs547710171 | c.1163G>A | p.Arg388Gln | p.R388Q | Q8N5C6 | protein_coding | deleterious(0.01) | possibly_damaging(0.516) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SRBD1 | SNV | Missense_Mutation | c.2189N>C | p.Lys730Thr | p.K730T | Q8N5C6 | protein_coding | deleterious(0) | probably_damaging(0.92) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |